These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 12586604

  • 1. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
    Sung JL, Lin JT, Gorham JD.
    Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
    [Abstract] [Full Text] [Related]

  • 2. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
    Gunnlaugsdottir B, Maggadottir SM, Ludviksson BR.
    Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
    [Abstract] [Full Text] [Related]

  • 3. Naive human T-cells become non-responsive towards anti-TNFalpha (infliximab) treatment in vitro if co-stimulated through CD28.
    Gunnlaugsdottir B, Skaftadottir I, Ludviksson BR.
    Scand J Immunol; 2008 Dec; 68(6):624-34. PubMed ID: 19000096
    [Abstract] [Full Text] [Related]

  • 4. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
    Lee HM, Rich S.
    J Immunol; 1991 Aug 15; 147(4):1127-33. PubMed ID: 1831218
    [Abstract] [Full Text] [Related]

  • 5. Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains.
    Hoehn P, Goedert S, Germann T, Koelsch S, Jin S, Palm N, Ruede E, Schmitt E.
    J Immunol; 1995 Oct 15; 155(8):3788-93. PubMed ID: 7561083
    [Abstract] [Full Text] [Related]

  • 6. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW, Liao CH, Ying C, Chang CJ, Lin CM.
    Clin Immunol; 2006 Apr 15; 119(1):21-31. PubMed ID: 16406844
    [Abstract] [Full Text] [Related]

  • 7. Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody.
    Holsti MA, McArthur J, Allison JP, Raulet DH.
    J Immunol; 1994 Feb 15; 152(4):1618-28. PubMed ID: 7907103
    [Abstract] [Full Text] [Related]

  • 8. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
    Chen FL, Kung JT.
    J Immunol; 1996 Mar 15; 156(6):2036-44. PubMed ID: 8690890
    [Abstract] [Full Text] [Related]

  • 9. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK, Doyle LV.
    J Immunol; 1989 Sep 15; 143(6):1761-7. PubMed ID: 2570801
    [Abstract] [Full Text] [Related]

  • 10. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H.
    Int Immunol; 2005 Jan 15; 17(1):73-83. PubMed ID: 15569772
    [Abstract] [Full Text] [Related]

  • 11. Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production.
    Seder RA, Marth T, Sieve MC, Strober W, Letterio JJ, Roberts AB, Kelsall B.
    J Immunol; 1998 Jun 15; 160(12):5719-28. PubMed ID: 9637480
    [Abstract] [Full Text] [Related]

  • 12. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
    Liu Y, Amarnath S, Chen W.
    Transplantation; 2006 Oct 15; 82(7):953-64. PubMed ID: 17038912
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-7 activates human naive CD4+ cells and primes for interleukin-4 production.
    Webb LM, Foxwell BM, Feldmann M.
    Eur J Immunol; 1997 Mar 15; 27(3):633-40. PubMed ID: 9079802
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor beta 1 (TGF-beta1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs.
    Kawamoto K, Pahuja A, Hering BJ, Bansal-Pakala P.
    Transpl Immunol; 2010 May 15; 23(1-2):28-33. PubMed ID: 20307666
    [Abstract] [Full Text] [Related]

  • 15. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma.
    Schmitt E, Germann T, Goedert S, Hoehn P, Huels C, Koelsch S, Kühn R, Müller W, Palm N, Rüde E.
    J Immunol; 1994 Nov 01; 153(9):3989-96. PubMed ID: 7930607
    [Abstract] [Full Text] [Related]

  • 16. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
    Koehler H, Kofler D, Hombach A, Abken H.
    Cancer Res; 2007 Mar 01; 67(5):2265-73. PubMed ID: 17332357
    [Abstract] [Full Text] [Related]

  • 17. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P, de Ojeda G, Criado G, Fernández-Centeno E, Rojo JM.
    Cell Immunol; 1999 Aug 01; 195(2):96-109. PubMed ID: 10448009
    [Abstract] [Full Text] [Related]

  • 18. The regulatory function of umbilical cord blood CD4(+) CD25(+) T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15.
    Lee CC, Lin SJ, Cheng PJ, Kuo ML.
    Pediatr Allergy Immunol; 2009 Nov 01; 20(7):624-32. PubMed ID: 19302176
    [Abstract] [Full Text] [Related]

  • 19. Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: implications for dendritic cell immunization against cancer.
    Lin CM, Wang FH, Lee PK.
    Clin Immunol; 2002 Jan 01; 102(1):96-105. PubMed ID: 11781072
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S, Seelig M, Lee HM, Lin J.
    J Immunol; 1995 Jul 15; 155(2):609-18. PubMed ID: 7608539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.